169 related articles for article (PubMed ID: 31094773)
1. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
[TBL] [Abstract][Full Text] [Related]
2. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
[TBL] [Abstract][Full Text] [Related]
3. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
4. Interpreting coagulation mixing study results in the era of direct oral anticoagulants.
Kim MJ; Salazar E; Philips B; Rice L; Castillo B; Leveque C; Chen J
Blood Coagul Fibrinolysis; 2024 Jan; 35(1):23-26. PubMed ID: 37994629
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
Song J; Jung HW; Lee EH; Chang HK; Yoon HS
Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
[TBL] [Abstract][Full Text] [Related]
6. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
7. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).
Gosselin RC
Methods Mol Biol; 2023; 2663():289-295. PubMed ID: 37204718
[TBL] [Abstract][Full Text] [Related]
8. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
9. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
Testa S; Legnani C; Tripodi A; Paoletti O; Pengo V; Abbate R; Bassi L; Carraro P; Cini M; Paniccia R; Poli D; Palareti G
J Thromb Haemost; 2016 Nov; 14(11):2194-2201. PubMed ID: 27566988
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of coagulation time: PT and APTT].
Ramakers C; van der Heul C; van Wijk EM
Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
[TBL] [Abstract][Full Text] [Related]
11. Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon.
Frans G; Meeus P; Bailleul E
J Thromb Haemost; 2019 Aug; 17(8):1354-1362. PubMed ID: 31102433
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the utility of unselected coagulation screening in general hospital practice.
McHugh J; Holt C; O'Keeffe D
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):106-9. PubMed ID: 21245744
[TBL] [Abstract][Full Text] [Related]
13. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
Ząbczyk M; Kopytek M; Natorska J; Undas A
Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
[TBL] [Abstract][Full Text] [Related]
14. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
15. Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
Santoro RC; Molinari AC; Leotta M; Martini T
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374373
[TBL] [Abstract][Full Text] [Related]
16. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
Mani H; Herth N; Kasper A; Wendt T; Schuettfort G; Weil Y; Pfeilschifter W; Linnemann B; Herrmann E; Lindhoff-Last E
Ther Drug Monit; 2014 Oct; 36(5):624-31. PubMed ID: 24577124
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Activated Partial Thromboplastin Time Mixing Studies Using Several Methods.
Liu C; Ling L; Huang X; Mi J; Liao J; Jia J; Wang X; Zhou J
Arch Pathol Lab Med; 2022 Nov; 146(11):1387-1394. PubMed ID: 35271692
[TBL] [Abstract][Full Text] [Related]
19. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review.
Rasmussen KL; Philips M; Tripodi A; Goetze JP
Eur J Haematol; 2020 Jun; 104(6):519-525. PubMed ID: 32049377
[TBL] [Abstract][Full Text] [Related]
20. Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art.
Adcock DM; Moore GW; Montalvão SL; Kershaw G; Gosselin RC
Semin Thromb Hemost; 2023 Sep; 49(6):571-579. PubMed ID: 36055261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
